Keith Henry

机构：Hennepin Healthcare Research Institute · ORCID：0000-0003-3515-7748

发表论文 475 篇 · 总被引 11053 次 · h-index 58

代表论文

• Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial (2021 · The Lancet HIV · 被引 91)
• Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria (2021 · AIDS · 被引 13)
• Pneumoproteins and biomarkers of inflammation and coagulation do not predict rapid lung function decline in people living with HIV (2023 · Scientific Reports · 被引 4)
• 1028. Long-term Follow-up After a Switch to Bictegravir, Emtracitabine, Tenofovir Alafenamide from Dolutegravir, Abacavir, Lamivudine (2020 · Open Forum Infectious Diseases · 被引 4)
• Efficacy and safety of switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir/abacavir/lamivudine: Results from an open-label extension of a phase 3 randomized, double-blind, multicenter, active-controlled, non-inferiority study (2025 · Medicine · 被引 3)
• “I have established this support network”: How Chosen Kin Support Women Medical Students During their First Two Years in Medical School (2024 · Teaching and Learning in Medicine · 被引 3)